01.05.24 -- A Pathway Forward In Neuroscience Therapies

The 2024 PDA Annual Meeting promises to be nothing short of epic! Get ready for plenary speakers who will ignite your imagination, technical presentations and high-energy roundtable discussions to keep you at the top of the industry, and networking opportunities to connect you with the best minds in pharma! Top that off with industry site visits and fun and engaging social activities! Register now.

Can a nested financial business model help bring the next generation of neuroscience treatments to patients?

A robust and competitive M&A environment in 2024 will require dealmakers to exercise greater discernment and discipline in target selection and pricing strategies.

New FDA draft guidance on interchangeability and new biosimilar products entering the market could disrupt the competitive landscape in 2024.

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.